ulcerative colitis
Wellcome Sanger Institute, Open Targets Fund Inflammatory Bowel Disease Biomarker Study
Researchers will analyze multiomic and clinical data from 1,000 patients with IBD recruited from seven participating hospitals in the UK.
Palisade Bio, Strand Life Sciences Partner for Ulcerative Colitis Precision Medicine
Palisade will apply Strand's bioinformatics capabilities to analyze its patient datasets for therapy-responsive patients.
RCSI researchers have found a set of genes that are highly expressed in ulcerative colitis patients who progress to further stages of the disease that they hope to use in a diagnostic test.
Merck Closes $10.8B Prometheus Biosciences Acquisition
Prometheus' lead candidate being developed for ulcerative colitis and Crohn's disease, PRA-023, will be renamed MK-7240.
NImmune Biopharma, NIMML Institute Collaborating on Precision Immunoregulatory Drugs
NImmune will gain access to NIMML's AI-driven platform and to its research, development, and regulatory infrastructure.
Apr 17, 2023